Notizia - Recent Pharma, Healthcare and Biotech Happenings

J&J collaborates with BARDA to accelerate coronavirus vaccine program Johnson & Johnson has collaborated with the U.S. Biomedical Advanced Research and Development Authority (BARDA) to produce a vaccine against novel coronavirus. J&J is attempting to pool money and resources with BARDA in order to quick the progress of the drug into phase 1 development.   J&J had joined the biopharma companies that are working to halt the coronavirus, now radiating out from Wuhan, China. The giant had sketched out a multipronged approach against the virus that positioned it to proffer antivirals for use in China while giving its AdVac and PER.C6 technologies to t...